Is combined androgen blockade with bicalutamide cost-effective compared with combined androgen blockade with flutamide?

Ramsey S, Veenstra D, Clarke L, Gandhi S, Hirsch M, Penson D
Urology. 2005 66 (4): 835-9

PMID: 16230148 · DOI:10.1016/j.urology.2005.04.028

MeSH Terms (11)

Androgen Antagonists Anilides Antineoplastic Agents Cost-Benefit Analysis Drug Therapy, Combination Flutamide Humans Male Nitriles Prostatic Neoplasms Tosyl Compounds

Connections (1)

This publication is referenced by other Labnodes entities: